AuthorsPatients with ODPatients with OD + GDMode of collecting dataObjective assessment of ODOnset of OD (days)Duration of OD (days)Recovery time (days)Treatment given
Lechien et al34357/417 (85.6%), anosmia: 284 (79.6%); hyposmia: 73 (20.4%); phantosmia: 12.6%; and parosmia: 32.4%Anosmia-16 (37.2%) Hyposmia-4 (9.3%)Questionnaire-9.77±5.68, before: 11.8%, after: 65.4%, concomitant: 22.8%-Anosmia: 1-4 (33.0%), 5-8 (39.6%), 9-14 (24.2%), and >15 (3.3%)Oral/nasal corticosteroids: 70.0/8.0%; nasal saline irrigation: 17.0%; other: 3.0%
Hopkin et al35Anosmia: 1796/2428 (74.4%)-Email-<7 (n=1487; 61.0%) Before-14.9%; concomitant-39.3%; after-45.8%--Nasal steroids; 20 patients; only 3-oral steroids
Jalessi et al3622/100 (23.9%), anosmia:9 (40.9%); hyposmia: 13 (59.1%); hyperosmia: 2-Questionnaire-First symptom-6.5% Time of onset-3.41±2.4610.73±8.2621 (95.4%)-
Lechien et al37Anosmia: 16/16-QuestionnaireThe mean SNOT-22 score - 28.8±18.0; mean Sniffin’ Stick score-4.6±1.7At presentation-100%-19.8±12.8-
Valeria Dell’Era et al38Anosmia: 14/355 (3.9%)249/355 (70.0%)Medical records and interviewBaseline smell perception of 10 (range: 3-10)First symptom-8.7%-14.0-49.5%-
Villarreal et al39Anosmia: 157/230 (68.0%)-QuestionnaireAverage OD-8.2 in the modified VAS (range: 2-10)-11>28.0-26.0%-
Qiu et al40Anosmia: 61/394 (15.0%)93/394 (240.0%)Medical recordsMild-54.0%; moderate-37.0%; severe-17.0% Mean VAS score-3.60±3.62 (IQR: 0-7) The mean scores of QOD-QoL 37.0%/23.0%----
Tham et al41Anosmia: 126/1065 (11.8%)41/1065 (3.9%)Questionnaire--14--
Naeinia et al4249/49, anosmia: 42 (85.7%); hyposmia: 7 (14.3%)-Questionnaire-Sudden onset-91.8%---
Otte et al4341/91 (45.0%), normosmic:49, hyposmic: 4180/91 (90.9%)QuestionnaireOdour T: 6.31±0.25; odour D: 11.63±0.26; odour I: 12.92±0.21; TDI score: 30.87±0.557.94±1.40---
Al-Ani et al44Anosmia: 7/141 (5.0%)12/141 (8.5%)Medical records--6.89±3.0563-12-
Altin et al45Anosmia: 29/81 (35.8%)20 (24.7%)Questionnaire-----
D’Ascanio et al4626/43, partial hyposmia: 6 (23.0%); Total anosmia: 20 (77.0%)-Questionnaire-Concomitant-07; before-04530-
Cazolla et al4744/67 (65.7%), anosmia: 10 (22.7%); hyposmia: 34/676 (8.9%)QuestionnaireVAS scores: severe-38.6%; moderate-29.6%; mild-9.1%-10±635 (52.2%)-14-

OD: olfactory dysfunction, GD: gustatory dysfunction, SNOT: sinonasal outcome test, IQR: interquartile range, VAS: visual analog scale, T: threshold, D: discrimination, I: identification